Convalescent plasma therapy for the treatment of patients with COVID‐19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levels

INTRODUCTION: The lack of approved specific therapeutic agents to treat coronavirus disease (COVID‐19) associated with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection has led to the rapid implementation of convalescent plasma therapy (CPT) trials in many countries, including t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transfus Med
Main Authors: Harvala, Heli, Robb, Matthew L., Watkins, Nick, Ijaz, Samreen, Dicks, Steven, Patel, Monika, Supasa, Piyada, Wanwisa, Dejnirattisai, Liu, Chang, Mongkolsapaya, Juthathip, Bown, Abbie, Bailey, Daniel, Vipond, Richard, Grayson, Nicholas, Temperton, Nigel, Gupta, Sunetra, Ploeg, Rutger J., Bolton, Jai, Fyfe, Alex, Gopal, Robin, Simmonds, Peter, Screaton, Gavin, Thompson, Craig, Brooks, Tim, Zambon, Maria, Miflin, Gail, Roberts, David J.
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 2020
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8246874/
https://ncbi.nlm.nih.gov/pubmed/33333627
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tme.12746
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados